Journal Mobile Options
Table of Contents
Vol. 74, No. 2, 1985
Issue release date: 1985
Section title: Correspondence
Acta Haematol 1985;74:120
(DOI:10.1159/000206184)

Danazol in Idiopathic Thrombocytopenic Purpura

Almagro D.
Habana

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.


First-Page Preview
Abstract of Correspondence

  

Author Contacts

D. Almagro, MD, Institute of Hematology and Immunology, PO Box 8070, Ciudad de La Habana 8 (Cuba)

  

Article Information

Accepted: August 5, 1985
Published online: February 25, 2009
Number of Print Pages : 1

  

Publication Details

Acta Haematologica

Vol. 74, No. 2, Year 1985 (Cover Date: 1985)

Journal Editor: Ben-Bassat I. (Qiryat-Ono)
ISSN: 0001-5792 (Print), eISSN: 1421-9662 (Online)

For additional information: http://www.karger.com/AHA


Article / Publication Details

Accepted: 8/5/1985
Published online: 2/25/2009

Number of Print Pages: 1
Number of Figures: 0
Number of Tables: 0

ISSN: 0001-5792 (Print)
eISSN: 1421-9662 (Online)

For additional information: http://www.karger.com/AHA


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.